Ascentage Pharma Group International Unsponsored ADR Income Statement
Last quarter (Q2 2024), Ascentage Pharma Group International Unsponsored ADR's total revenue was $―, a decrease of ― from previous quarter. In Q2, Ascentage Pharma Group International Unsponsored ADR's net income was $―. See Ascentage Pharma Group International Unsponsored ADR’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23
Dec 22
Total Revenue
$ ―
$ ―
Gross Profit
$ 191.44M
$ 193.86M
Operating Expenses
$ ―
$ ―
Depreciation and Amortization
$ ―
$ ―
EBITDA
$ -839.67M
$ -817.56M
Operating Income
$ -896.50M
$ -882.47M
Other Income/Expenses
$ ―
$ ―
Pretax Income
$ ―
$ ―
Net Income
$ -925.64M
$ -876.22M
Per Share Metrics
Basic EPS
$ ―
$ ―
Diluted EPS
$ ―
$ ―
Weighted Average Shares Outstanding
―
―
Weighted Average Shares Outstanding (Diluted)
―
―
Currency in USD
Ascentage Pharma Group International Unsponsored ADR Earnings and Revenue History